(amounts in millions, except share and per share data,


                             unless otherwise noted)






The following discussion and analysis of the results of operations and financial
condition for the three and six months ended June 30, 2020 and 2019 has been
derived from and should be read in conjunction with our unaudited condensed
consolidated financial statements and the accompanying notes included herein for
Amphenol Corporation (together with its subsidiaries, "Amphenol," the "Company,"
"we," "our," or "us"), which are prepared in accordance with accounting
principles generally accepted in the United States of America ("U.S. GAAP"). The
following discussion and analysis also includes references to certain non-GAAP
financial measures, which are defined in the "Non-GAAP Financial Measures"
section below, including "Constant Currency Net Sales Growth" and "Organic Net
Sales Growth". For purposes of the following discussion, the terms "constant
currencies" and "organically" have the same meaning, respectively, as these
aforementioned non-GAAP financial measures. Refer to "Non-GAAP Financial
Measures" within this Item 2 for more information, including our reasons for
including the non-GAAP financial measures and material limitations with respect
to the usefulness of the measures.





Safe Harbor Statement



This Quarterly Report on Form 10-Q includes forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995, which
relate to future events and are subject to risks and uncertainties. The
forward-looking statements, which address the Company's expected business and
financial performance and financial condition, among other matters, may contain
words and terms such as: "anticipate," "could," "continue," "expect,"
"estimate," "forecast," "ongoing," "project," "seek," "predict," "target,"
"will," "intend," "plan," "optimistic," "potential," "guidance," "may,"
"should," or "would" and other words and terms of similar meaning.



Forward-looking statements by their nature address matters that are, to
different degrees, uncertain, such as statements about expected earnings,
revenues, growth, liquidity or other financial matters, together with any
forward-looking statements related in any way to the COVID-19 pandemic including
its future impact on the Company. Although the Company believes the expectations
reflected in such forward-looking statements, including those with regards to
results of operations, liquidity or the Company's effective tax rate, are based
upon reasonable assumptions, the expectations may not be attained or there may
be material deviation. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date on which they
are made. There are risks and uncertainties that could cause actual results to
differ materially from these forward-looking statements, which include, but are
not limited to, the following: future risks and existing uncertainties
associated with the COVID-19 pandemic, which continues to have an adverse impact
on our operations, including, depending on the specific location, government
actions that limit our ability to operate certain of our facilities at full
capacity or at all, government actions that limit our ability to adjust certain
costs, travel restrictions, "work-from-home" orders and the gradual transition
back to the workplace, limited availability of our workforce in some locations,
supplier constraints, supply-chain interruptions, logistics challenges and
limitations, and reduced demand from certain customers; uncertainties associated
with a protracted economic slowdown that could negatively affect the financial
condition of our customers; uncertainties and volatility in the global capital
markets; political, economic, military and other risks in countries outside of
the United States; the impact of general economic conditions, geopolitical
conditions and U.S. trade policies, legislation, trade disputes, treaties and
tariffs, including those affecting China, on the Company's business operations;
risks associated with the improper conduct by any of our employees, customers,
suppliers, distributors or any other business partners which could impair our
business reputation and financial results and could result in our non-compliance
with anti-corruption laws and regulations of the U.S. government and various
foreign jurisdictions; changes in exchange rates of the various currencies in
which the Company conducts business; the Company's ability to obtain a
consistent supply of materials, at stable pricing levels; the Company's
dependence on sales to the communications industry, which markets are dominated
by large manufacturers and operators who regularly exert significant pressure on
suppliers, including the Company; changes in defense expenditures in the
military market, including the impact of reductions or changes in the defense
budgets of U.S. and foreign governments; the Company's ability to compete
successfully on the basis of technology innovation, product quality and
performance, price, customer service and delivery time; the Company's

                                       24

Table of Contents



ability to continue to conceive, design, manufacture and market new products and
upon continuing market acceptance of its existing and future product lines;
difficulties and unanticipated expenses in connection with purchasing and
integrating newly acquired businesses, including the potential for the
impairment of goodwill and other intangible assets; events beyond the Company's
control that could lead to an inability to meet its financial covenants which
could result in a default under the Company's revolving credit facility; the
Company's ability to access the capital markets on favorable terms, including as
a result of significant deterioration of general economic or capital market
conditions, or as a result of a downgrade in the Company's credit rating;
changes in interest rates; government contracting risks that the Company may be
subject to, including laws and regulations governing performance of U.S.
government contracts and related risks associated with conducting business with
the U.S. government or its suppliers (both directly and indirectly);
governmental export and import controls that certain of our products may be
subject to, including export licensing, customs regulations, economic sanctions
or other laws; cybersecurity threats or incidents that could arise on our
information technology systems which could disrupt business operations and
adversely impact our reputation and operating results and potentially lead to
litigation and/or governmental investigations; changes in fiscal and tax
policies, audits and examinations by taxing authorities, laws, regulations and
guidance in the United States and foreign jurisdictions, including related
interpretations of certain provisions of the U.S. Tax Cuts and Jobs Act of 2017
("Tax Act"); any difficulties in protecting the Company's intellectual property
rights; and litigation, customer claims, product recalls, governmental
investigations, criminal liability or environmental matters including changes to
laws and regulations to which the Company may be subject. In addition, the
extent to which the COVID-19 pandemic will continue to impact our business and
financial results going forward will be dependent on future developments such as
the length and severity of the crisis, the potential resurgence of the crisis,
future government actions in response to the crisis and the overall impact of
the COVID-19 pandemic on the global economy and capital markets, among many
other factors, all of which remain highly uncertain and unpredictable. Such
forward-looking statements may also be impacted by, among other things,
additional guidance under the Tax Act. While the Company completed its
accounting of the Tax Act in the fourth quarter of 2018 based on the regulatory
guidance issued at that time, the Department of Treasury's interpretive guidance
initiatives are ongoing. Any future guidance on the Tax Act could impact our
forward-looking statements.



A further description of these uncertainties and other risks can be found in the
Company's Annual Report on Form 10-K for the year ended December 31, 2019,
Quarterly Reports on Form 10-Q and the Company's other reports filed with the
Securities and Exchange Commission. These or other uncertainties may cause the
Company's actual future results to be materially different from those expressed
in any forward-looking statements. The Company undertakes no obligation to
update or revise any forward-looking statements except as required by law.

Impact of Coronavirus ("COVID-19") on our Operations, Financial Condition, Liquidity and Results of Operations





The COVID-19 pandemic has caused widespread disruptions to our Company during
both the second quarter and first six months of 2020.  During the first quarter,
these disruptions were primarily limited to our operations in China, which were
closed for three weeks during January and February due to government mandates.
As the virus spread to the rest of the world beginning in March and continuing
throughout the second quarter of 2020, most of our other operations outside of
China were then also impacted.  As of June 30, 2020, we continue to experience
disruptions, and at a minimum, we expect those disruptions to continue
throughout the second half of 2020.  These disruptions have included and may
continue to include, depending on the specific location, government actions that
limit our ability to operate certain of our facilities at full capacity or at
all, government actions that limit our ability to adjust certain costs, travel
restrictions, "work-from-home" orders and the gradual transition back to the
workplace, limited availability of our workforce in some locations, supplier
constraints, supply-chain interruptions, logistics challenges and limitations,
and reduced demand from certain customers.  As noted below within this Item 2,
the COVID-19 pandemic did have a negative impact on our results for both our
second quarter and our first six months of 2020, and we expect it to continue to
have a negative impact on our second half of 2020 results. The extent of the
impact on our second half of 2020 results and beyond will be dependent on future
developments such as the length and severity of the crisis, the potential
resurgence of the crisis, future government actions in response to the crisis
and the overall impact of the COVID-19 pandemic on the global economy and
capital markets, among many other factors, all of which remain highly uncertain
and unpredictable.  Given this uncertainty, the Company is currently unable to
quantify the expected impact of the COVID-19 pandemic on its future operations,
financial condition, liquidity and results of operations.  In addition, the

                                       25

Table of Contents


COVID-19 pandemic could impact the health of our management team and other
employees. The Company continues taking actions to help mitigate, as best we
can, the impact of the COVID-19 pandemic on the health and well-being of our
employees, the communities in which we operate and our partners, as well as the
impact on our operations and business as a whole.  However, there can be no
assurance that the COVID-19 pandemic will not have a material and adverse impact
on our operations, financial condition, liquidity and results of operations.



Results of Operations


Three and six months ended June 30, 2020 compared to the three and six months ended June 30, 2019


Net sales were $1,987.5 in the second quarter of 2020 compared to $2,015.3 in
the second quarter of 2019, which represented a decrease of 1% in U.S. dollars
and 3% organically, while flat in constant currencies, over the respective prior
year period. Net sales were $3,849.5 in the first six months of 2020 compared to
$3,973.8 in the first six months of 2019, which represented a decrease of 3% in
U.S. dollars, 2% in constant currencies and 6% organically, over the respective
prior year period. The decrease in net sales during the second quarter and first
six months of 2020 relative to the comparable periods in 2019 was driven
primarily by the sudden and severe slowdown in certain of our markets resulting
from the global outbreak of the COVID-19 pandemic, which also resulted in
production limitations imposed in many parts of the world during much of the
first and second quarters of 2020.



Net sales in the Interconnect Products and Assemblies segment (approximately 96%
of net sales) in the second quarter of 2020 decreased 1% in U.S. dollars and 3%
organically, while flat in constant currencies, compared to the second quarter
of 2019. The decline in net sales in the Interconnect Products and Assemblies
segment during the second quarter of 2020 relative to the comparable period in
2019 was driven by significant declines in the automotive and commercial
aerospace markets, along with moderations in the mobile networks and military
markets, all of which were negatively impacted by the COVID-19 pandemic, largely
offset by strong growth in the information technology and data communications,
mobile devices and industrial markets as well as contributions from the
Company's acquisition program. Net sales in the Interconnect Products and
Assemblies segment (approximately 96% of net sales) in the first six months of
2020 decreased 3% in U.S. dollars, 2% in constant currencies and 6% organically,
compared to the first six months of 2019. The decline in net sales in the
Interconnect Products and Assemblies segment during the first six months of 2020
relative to the comparable period in 2019 was driven by a significant decline in
the automotive, mobile networks and commercial aerospace markets, all of which
were negatively impacted by the COVID-19 pandemic, offset in part by strong
growth in the information technology and data communications market and moderate
growth in the industrial and military markets, along with contributions from the
Company's acquisition program.



Net sales in the Cable Products and Solutions segment (approximately 4% of net
sales) in the second quarter of 2020, which primarily serves the broadband
communications market, decreased 1% in U.S. dollars, while increasing 3% in
constant currencies and 3% organically, compared to the second quarter of 2019.
Net sales in the Cable Products and Solutions segment (approximately 4% of net
sales) in the first six months of 2020 decreased 7% in U.S. dollars, 4% in
constant currencies and 4% organically, compared to the first six months of
2019. The modest decline in net sales in the Cable Products and Solutions
segment for the first six months of 2020 was primarily driven by the negative
impact of the COVID-19 pandemic on our ability to produce products in the first
quarter of 2020 as well as overall weakness in market demand.



                                       26

  Table of Contents

The table below reconciles Constant Currency Net Sales Growth and Organic Net
Sales Growth to the most directly comparable U.S. GAAP financial measures for
the three and six months ended June 30, 2020 compared to the three and six
months ended June 30, 2019:




                                                                                   Percentage Growth (relative to same prior year period)


                                                                     Net sales           Foreign           Constant                              Organic
                                                                     growth in          currency         Currency Net         Acquisition       Net Sales
                                                                  U.S. Dollars (1)     impact (2)      Sales Growth (3)       impact (4)        Growth (3)
Three Months Ended June 30:              2020         2019             (GAAP)          (non-GAAP)         (non-GAAP)          (non-GAAP)        (non-GAAP)
Net sales:

Interconnect Products and Assemblies   $ 1,898.5    $ 1,925.6           (1)

%             (1) %                 - %              3 %               (3) %
Cable Products and Solutions                89.0         89.7           (1) %             (4) %                 3 %              - %                 3 %
Consolidated                           $ 1,987.5    $ 2,015.3           (1) %             (1) %                 - %              3 %               (3) %

Six Months Ended June 30:
Net sales:

Interconnect Products and Assemblies   $ 3,677.5    $ 3,788.3           (3)

%             (1) %               (2) %              4 %               (6) %
Cable Products and Solutions               172.0        185.5           (7) %             (3) %               (4) %              - %               (4) %
Consolidated                           $ 3,849.5    $ 3,973.8           (3) %             (1) %               (2) %              4 %               (6) %


Net sales growth in U.S. dollars is calculated based on Net sales as reported

in the Condensed Consolidated Statements of Income and Note 13 of the

accompanying financial statements. While the term "net sales growth in U.S. (1) dollars" is not considered a U.S. GAAP financial measure, for purposes of

this table, we derive the reported (GAAP) measure based on GAAP results,

which serves as the basis for the reconciliation to its comparable non-GAAP


    financial measures.


    Foreign currency translation impact, a non-GAAP measure, represents the

impact on net sales resulting from foreign currency exchange rate changes in

the current year period(s) compared to the same period(s) in the prior year. (2) Such amount is calculated by subtracting current year net sales translated at

average foreign currency exchange rates for the respective prior periods from

current year reported net sales, taken as a percentage of the respective

prior period net sales.

(3) Constant Currency Net Sales Growth and Organic Net Sales Growth are non-GAAP

financial measures as defined in the "Non-GAAP Financial Measures" section.

Acquisition impact, a non-GAAP measure, represents the impact on net sales

resulting from acquisitions closed since the beginning of the prior calendar (4) year, which were not included in the Company's results as of the comparable

prior year periods and which do not reflect the underlying growth of the


    Company on a comparative basis.




Geographically, sales in the United States in the second quarter of 2020
decreased approximately 10% in U.S. dollars ($569.8 in 2020 versus $632.8 in
2019) and 14% organically, compared to the second quarter of 2019. Sales in the
United States in the first six months of 2020 decreased 2% in U.S. dollars
($1,185.2 in 2020 versus $1,211.7 in 2019) and 8% organically, compared to the
first six months of 2019. Foreign sales in the second quarter of 2020 increased
approximately 3% in U.S. dollars ($1,417.7 in 2020 versus $1,382.5 in 2019), 4%
in constant currencies and 2% organically, compared to the second quarter of
2019. Foreign sales in the first six months of 2020 decreased approximately 4%
in U.S. dollars ($2,664.3 in 2020 versus $2,762.1 in 2019), 2% in constant
currencies and 5% organically, compared to the first six months of 2019. The
comparatively stronger U.S. dollar for the second quarter and first six months
of 2020 had the effect of decreasing sales by approximately $21.7 and $40.4,
respectively, relative to the comparable periods in 2019.



Selling, general and administrative expenses increased to $246.4, or 12.4% of
net sales, and $489.3, or 12.7% of net sales, for the second quarter and first
six months of 2020, respectively, compared to $239.2, or 11.9% of net sales, and
$474.3, or 11.9% of net sales, for the second quarter and first six months of
2019. The increase in selling, general and administrative expenses as a
percentage of net sales in both the second quarter and first six months of 2020
is primarily driven by lower sales during the second quarter and first six
months of 2020 relative to the comparable periods of 2019, and by government
actions imposed in response to the COVID-19 pandemic that limited the Company's
ability to adjust costs. Administrative expenses represented approximately 5.0%
and 5.1% of net sales for the second quarter and first six months of 2020,
respectively, and represented approximately 4.6% of net sales for both the
second quarter and first six months of 2019. Research and development expenses
represented approximately 3.1% of net sales for both the second quarter and
first six months of 2020, and represented approximately 2.9% of net sales for
both the second quarter and first six months of 2019. Selling and marketing
expenses represented approximately 4.3% and 4.5% of net sales for the second
quarter and first six months of 2020, respectively, and represented
approximately 4.4% of net sales for both the second quarter and first six months
of 2019.



Operating income was $357.4, or 18.0% of net sales, and $674.3, or 17.5% of net
sales, for the second quarter and first six months of 2020, respectively,
compared to $399.5, or 19.8% of net sales, and $775.7, or 19.5% of net sales,
for the second quarter and first six months of 2019, respectively. Operating
income for the second quarter of 2019 included

                                       27

Table of Contents

$8.9 of acquisition-related expenses (separately presented in the Condensed
Consolidated Statements of Income) comprised primarily of external transaction
costs of $5.7, as well as the amortization of $3.2 related to the value
associated with acquired backlog from an acquisition which closed in the second
quarter of 2019. Operating income for the first six months of 2019 included
$25.4 of acquisition-related expenses (separately presented in the Condensed
Consolidated Statements of Income) comprised of the amortization of $15.7
related to the value associated with acquired backlog from two acquisitions, as
well as external transaction costs of $9.7. For the three and six months ended
June 30, 2019, these acquisition-related expenses had the effect of decreasing
net income by $7.8, or $0.03 per share and $21.0, or $0.07 per share,
respectively. Excluding the effect of these acquisition-related expenses,
Adjusted Operating Income and Adjusted Operating Margin, as defined in the
"Non-GAAP Financial Measures" section below, was $408.4, or 20.3% of net sales
and $801.1, or 20.2% of net sales, for the three and six months ended June

30,
2019, respectively.



Operating income for the Interconnect Products and Assemblies segment for the
second quarter and first six months of 2020 was $379.5, or 20.0% of net sales,
and $719.2, or 19.6% of net sales, respectively, compared to $428.4, or 22.2% of
net sales, and $838.5, or 22.1% of net sales, for the second quarter and first
six months of 2019, respectively. The decrease in operating margin for the
Interconnect Products and Assemblies segment for the second quarter and first
six months of 2020 relative to the comparable periods in 2019 was somewhat
larger than our typical reduction in profitability given the corresponding sales
decline. This larger than typical decrease was due to the impact of the COVID-19
pandemic, which led to an extended shutdown in China during a three-week period
in January and February and significant disruption to production and
productivity in other parts of the world beginning in March and continuing
through much of the second quarter of 2020. As noted above, many government
actions imposed in response to the COVID-19 pandemic also limited the Company's
ability to adjust costs. The operating margin in the second quarter and first
six months of 2020 was also negatively impacted, to a lesser extent, by 2019
acquisitions which currently have, on average, a lower operating margin than the
average of the Interconnect Products and Assemblies segment for such periods.



Operating income for the Cable Products and Solutions segment for the second
quarter and first six months of 2020 was $8.4, or 9.4% of net sales, and $14.8,
or 8.6% of net sales, respectively, compared to $8.7, or 9.7% of net sales, and
$19.1, or 10.3% of net sales, for the second quarter and first six months of
2019, respectively. The decrease in operating margin for the Cable Products and
Solutions segment for both the second quarter and first six months of 2020
relative to the comparable periods in 2019 was primarily driven by lower volumes
as well as the negative impact of the COVID-19 pandemic on our ability to
produce products and adjust certain costs.



Interest expense for the second quarter and first six months of 2020 was $30.2
and $59.0, respectively, compared to $30.0 and $59.7 for the second quarter and
first six months of 2019, respectively. Refer to Note 4 of the Condensed
Consolidated Financial Statements for further information related to the
Company's debt.



Provision for income taxes for the second quarter and first six months of 2020
was at an effective tax rate of 20.7% and 18.5%, respectively. Provision for
income taxes for the second quarter and first six months of 2019 was at an
effective tax rate of 21.3% and 22.0%, respectively. For the second quarter and
first six months of 2020 and 2019, the excess tax benefits resulting from stock
option exercise activity had the impact of lowering the effective tax rate and
increasing earnings per share by the amounts noted in the tables below. For the
first six months of 2020, the effective tax rate was also impacted by a discrete
tax benefit related to the settlements of refund claims in certain non-U.S.
jurisdictions and the resulting adjustments to deferred taxes, which had the
impact of decreasing the effective tax rate and increasing earnings per share by
the amounts noted in the tables below. For the second quarter and first six
months of 2019, the effective tax rate was further impacted by the tax effect of
acquisition-related expenses, as noted in the tables below. Excluding the effect
of these items, the Adjusted Effective Tax Rate, a non-GAAP financial measure as
defined in the "Non-GAAP Financial Measures" section below within this Item 2,
for the three and six months ended June 30, 2020 and 2019 was 24.5% for all
periods, as reconciled in the tables below to the comparable effective tax rate
based on GAAP results. Refer to Note 6 of the Condensed Consolidated Financial
Statements for further information related to income taxes.



Net income attributable to Amphenol Corporation and Net income per common share-Diluted ("Diluted EPS") were $257.7 and $0.85, respectively, for the second quarter of 2020, compared to $288.4 and $0.93, respectively, for the second quarter of 2019. Excluding the effect of the aforementioned items discussed above, Adjusted Net Income



                                       28

Table of Contents



attributable to Amphenol Corporation and Adjusted Diluted EPS, non-GAAP
financial measures as defined in the "Non-GAAP Financial Measures" section below
within this Item 2, were $245.3 and $0.81, respectively, for the second quarter
of 2020, compared to $283.3 and $0.92, respectively, for the second quarter of
2019. Net income attributable to Amphenol Corporation and Diluted EPS were
$499.8 and $1.64, respectively, for the first six months of 2020, compared to
$556.0 and $1.80, respectively, for the first six months of 2019. Excluding the
effect of the aforementioned items discussed above, Adjusted Net Income
attributable to Amphenol Corporation and Adjusted Diluted EPS were $462.5 and
$1.52, respectively, for the first six months of 2020, compared to $557.3 and
$1.81, respectively, for the first six months of 2019.



The following tables reconcile Adjusted Operating Income, Adjusted Operating
Margin, Adjusted Net Income attributable to Amphenol Corporation, Adjusted
Effective Tax Rate and Adjusted Diluted EPS (all defined in the "Non-GAAP
Financial Measures" section below) to the most directly comparable U.S. GAAP
financial measures for the three and six months ended June 30, 2020 and 2019:




                                                                                 Three Months Ended June 30,
                                                         2020                                                                   2019
                                                        Net Income                                                             Net Income
                                                       attributable     Effective                                             attributable     Effective
                           Operating     Operating      to Amphenol        Tax       Diluted      Operating     Operating      to Amphenol        Tax       Diluted
                            Income       Margin (1)     Corporation     Rate (1)       EPS         Income       Margin (1)     Corporation     Rate (1)       EPS
Reported (GAAP)           $     357.4          18.0 %  $       257.7         20.7 %  $   0.85    $     399.5          19.8 %  $       288.4         21.3 %  $   0.93
Acquisition-related
expenses                            -             -                -            -           -            8.9           0.5              7.8        (0.3)        0.03
Excess tax benefits
related to stock-based
compensation                        -             -           (12.4)          3.8      (0.04)              -             -           (12.9)          3.5      (0.04)
Adjusted (non-GAAP)       $     357.4          18.0 %  $       245.3         24.5 %  $   0.81    $     408.4          20.3 %  $       283.3         24.5 %  $   0.92









                                                                                  Six Months Ended June 30,
                                                         2020                                                                   2019
                                                        Net Income                                                             Net Income
                                                       attributable     Effective                                             attributable     Effective
                           Operating     Operating      to Amphenol        Tax       Diluted      Operating     Operating      to Amphenol        Tax       Diluted
                            Income       Margin (1)     Corporation     Rate (1)       EPS         Income       Margin (1)     Corporation     Rate (1)       EPS
Reported (GAAP)           $     674.3          17.5 %  $       499.8         18.5 %  $   1.64    $     775.7          19.5 %  $       556.0         22.0 %  $   1.80
Acquisition-related
expenses                            -             -                -            -           -           25.4           0.7             21.0        (0.2)        0.07
Excess tax benefits
related to stock-based
compensation                        -             -           (17.4)          2.8      (0.06)              -             -           (19.7)          2.7      (0.06)
Discrete tax item                   -             -           (19.9)          3.2      (0.06)              -             -                -            -           -
Adjusted (non-GAAP)       $     674.3          17.5 %  $       462.5         24.5 %  $   1.52    $     801.1          20.2 %  $       557.3         24.5 %  $   1.81

While the terms "operating margin" and "effective tax rate" are not (1) considered U.S. GAAP financial measures, for purposes of this table, we

derive the reported (GAAP) measures based on GAAP results, which serve as the

basis for the reconciliation to their comparable non-GAAP financial measure.

Liquidity and Capital Resources





The COVID-19 pandemic created significant economic uncertainty and volatility in
the global credit and capital markets beginning in March 2020 and continuing
into the second quarter of 2020. In response, out of an abundance of caution, in
late March 2020, the Company borrowed $1,255.6 under its $2,500.0 Revolving
Credit Facility. In addition, due to the significant volatility in the
commercial paper markets, the Company also reduced its reliance on those markets
and, as such, approximately half of the proceeds from the Revolving Credit
Facility were used to repay amounts due under our Commercial Paper Programs (as
defined below) as they matured. During the second quarter of 2020, as the global
credit and capital markets stabilized and our liquidity position remained
strong, the Company used cash and cash equivalents on hand, along with the net
proceeds of the €500.0 0.750% Euro Senior Notes issued in May 2020 (discussed
further below), to repay all of the outstanding borrowings under the Revolving
Credit Facility; as such, there were no outstanding borrowings under the
Commercial Paper Programs or the Revolving Credit Facility as of June 30,

                                       29

Table of Contents

2020. As of June 30, 2020 and December 31, 2019, the Company had cash, cash equivalents and short-term investments of $1,314.0 and $908.6, respectively, with the vast majority of such funds located outside of the United States.


As a result of the Tax Act, on December 31, 2017, the Company indicated an
intention to repatriate most of its pre-2018 accumulated earnings and recorded
the foreign and U.S. state and local tax costs related to the repatriation. The
associated tax payments are due as the repatriations are made. The Company
intends to distribute certain post-2017 foreign earnings and has accrued foreign
and U.S. state and local taxes, if applicable, on those earnings as appropriate
as of June 30, 2020, and intends to indefinitely reinvest all remaining
post-2017 foreign earnings. The Company intends to evaluate future earnings for
distribution, and accrue for those distributions where appropriate, and to
indefinitely reinvest all other foreign earnings. In addition, the Transition
Tax on the deemed repatriation of the accumulated unremitted earnings and
profits of foreign subsidiaries will be paid, net of applicable tax credits and
deductions, in annual installments until 2025, as permitted under the Tax Act.



The Company's primary sources of liquidity are internally generated cash flow,
our cash, cash equivalents and short-term investments on hand, the Commercial
Paper Programs, and the Revolving Credit Facility.  The Company believes that
its cash, cash equivalents and short-term investment position on hand, ability
to generate future cash flow from operations, availability under its credit
facilities, and access to capital markets (including the recent issuances of the
2025 U.S. Senior Notes in February 2020 and the 2026 Euro Senior Notes in May
2020, as discussed further within this Item 2), provide adequate liquidity to
meet its obligations for at least the next twelve months.



The Company's primary ongoing cash requirements will be for operating and
capital expenditures, product development activities, repurchases of its Common
Stock, dividends, debt service, payments associated with the Transition Tax
(which is payable in annual installments until 2025), taxes due upon the
repatriation of foreign earnings (which will be payable upon the repatriation of
such earnings), and funding of pension obligations. The Company's debt service
requirements consist primarily of principal and interest on the Company's Senior
Notes, and to the extent of any amounts outstanding, the Revolving Credit
Facility and the Commercial Paper Programs (all as defined below). The Company
may also use cash to fund all or part of the cost of acquisitions.



Cash Flow Summary


The following table summarizes the Company's cash flows from operating, investing and financing activities for the six months ended June 30, 2020 and 2019, as reflected in the Condensed Consolidated Statements of Cash Flow:






                                                                   Six Months Ended June 30,
                                                                     2020               2019
Net cash provided by operating activities                       $        752.4     $        666.0
Net cash used in investing activities                                  (151.7)            (903.1)
Net cash used in financing activities                                  (191.4)             (55.0)
Effect of exchange rate changes on cash and cash equivalents            (12.2)              (4.9)
Net change in cash and cash equivalents                         $        397.1     $      (297.0)




Operating Activities



The ability to generate cash from operating activities is one of the Company's
fundamental financial strengths. Net cash provided by operating activities
("Operating Cash Flow") was $752.4 in the first six months of 2020 compared to
$666.0 in the first six months of 2019.  The increase in Operating Cash Flow for
the first six months of 2020 compared to the first six months of 2019 is
primarily due to a decrease in the components of working capital, which was
partially offset by the decrease in net income.



In the first six months of 2020, the components of working capital as presented
on the accompanying Condensed Consolidated Statements of Cash Flow decreased
$70.8, excluding the impact of acquisitions and foreign currency translation,
due to increases in accounts payable of $72.3 and accrued liabilities, including
income taxes, of $34.8, along with a decrease in accounts receivable of $54.8,
partially offset by increases in inventories of $69.3 and prepaid expenses and
other current assets of $21.8. In the first six months of 2019, the components
of working capital as presented on the accompanying Condensed Consolidated
Statements of Cash Flow increased $66.6, excluding the impact of acquisitions

                                       30

  Table of Contents

and foreign currency translation, due to decreases in accrued liabilities, including income taxes, of $124.6 and accounts payable of $107.0, partially offset by decreases in accounts receivable of $157.9 and inventories of $13.1.


The following describes the significant changes in the amounts as presented on
the accompanying Condensed Consolidated Balance Sheets at June 30, 2020 as
compared to December 31, 2019. Accounts receivable decreased $78.1 to $1,658.3.
Days sales outstanding at June 30, 2020 and December 31, 2019 were approximately
74 and 73 days, respectively. Inventories increased $51.8 to $1,361.9. Inventory
days at June 30, 2020 and December 31, 2019 were 89 and 80 days, respectively.
The more than typical increase in inventory days was primarily driven by the
depressed sales in the first six months of 2020 due to the required three-week
shutdown during January and February of the Company's manufacturing facilities
in China, along with the production limitations imposed in other parts of the
world beginning in March and continuing through much of the second quarter of
2020, all as a result of the COVID-19 pandemic. Prepaid expenses and other
current assets increased $27.7 to $283.8, primarily due to increases in certain
prepaid expenses and other current receivables. Property, plant and equipment,
net, increased $2.7 to $1,001.7, primarily due to capital expenditures of
$128.3, partially offset by depreciation of $115.5 as well as the effect of
translation from exchange rate changes at June 30, 2020 compared to December 31,
2019 ("Translation"). Other intangible assets, net decreased $25.8 to $416.2,
primarily due to the amortization related to the Company's intangible assets
during the first six months of 2020, along with Translation. Accounts payable
increased $61.2 to $928.0. Payable days at June 30, 2020 and December 31, 2019
were approximately 60 and 53 days, respectively. Total accrued expenses,
including accrued income taxes, decreased $7.7 to $854.9, primarily as a result
of the contingent consideration payment (related to the SSI acquisition) of
$75.0 in June 2020, along with a decrease in accrued income taxes, primarily
resulting from certain tax payments, partly offset by an increase in accrued
salaries and wages and other accrued expenses.



There is no current requirement for cash contributions to any of the Company's
defined benefit pension plans in the U.S., and the Company plans to evaluate
annually, based on actuarial calculations and the investment performance of the
pension plans' assets, the timing and amount of cash contributions in the
future, as discussed in more detail in Note 10 of the notes to the condensed
consolidated financial statements.



In addition to cash flow from operating activities, the Company also considers
Free Cash Flow, a non-GAAP financial measure defined in the "Non-GAAP Financial
Measures" section below, as a key metric in measuring the Company's ability to
generate cash. The following table reconciles Free Cash Flow to its most
directly comparable U.S. GAAP financial measure for the six months ended June
30, 2020 and 2019. The increase in Free Cash Flow is driven by the increase in
Operating Cash Flow, as described above, and to a lesser extent, a decrease

in
capital expenditures.




                                  Six Months Ended June 30,
                                    2020               2019
Operating Cash Flow (GAAP)     $        752.4     $        666.0
Capital expenditures (GAAP)           (128.3)            (149.9)
Free Cash Flow (non-GAAP)      $        624.1     $        516.1




Investing Activities



Cash flows from investing activities consist primarily of cash flows associated
with capital expenditures, proceeds from disposals of property, plant and
equipment, net sales and maturities (purchases) of short-term investments,

and
acquisitions.



Net cash used in investing activities was $151.7 in the first six months of
2020, compared to $903.1 in the first six months of 2019. In the first six
months of 2020, net cash used in investing activities was driven primarily by
capital expenditures (net of disposals) of $126.4, the use of $16.5 to fund
acquisitions, and net purchases of short-term investments of $8.8. In the first
six months of 2019, net cash used in investing activities was driven primarily
by the use of $756.2 to fund acquisitions, capital expenditures (net of
disposals) of $144.4, and net purchases of short-term investments of $2.5.




                                       31

  Table of Contents

Financing Activities


Cash flows from financing activities consist primarily of cash flows associated with borrowings and repayments of the Company's credit facilities and other long-term debt, repurchases of common stock, proceeds from stock option exercises, dividend payments, and distributions to and purchases of noncontrolling interests.


Net cash used in financing activities was $191.4 in the first six months of
2020, compared to $55.0 in the first six months of 2019. For the first six
months of 2020, net cash used in financing activities was driven primarily by
the repayment of the Company's 2.20% U.S. Senior Notes due April 2020 and other
debt of $401.3, net repayments related to the Company's commercial paper
programs of $385.2, repurchases of the Company's common stock of $257.2,
dividend payments of $148.4, payment related to acquisition-related contingent
consideration of $75.0, distributions to and purchases of noncontrolling
interests of $9.7, payments of costs of $8.7 related to debt financing primarily
associated with the 2025 Senior Notes and 2026 Euro Notes (each as defined
below), and net repayments under the Company's credit facilities of $0.7,
partially offset by the net cash proceeds from both the February 2020 issuance
of the 2025 Senior Notes and the May 2020 issuance of the 2026 Euro Notes of
$942.3 and cash proceeds from the exercise of stock options of $152.5. For the
first six months of 2019, net cash used in financing activities was driven
primarily by the repayment of the Company's 2.55% U.S. Senior Notes due January
2019 and other debt of $757.8, repurchases of the Company's common stock of
$408.7, dividend payments of $137.2, distributions to and purchases of
noncontrolling interests of $24.6, and payments of costs of $7.2 related to debt
financing primarily associated with the January 2019 issuance of the 4.350% U.S.
senior notes ("2029 Senior Notes") and the amended Revolving Credit Facility
(defined below), partially offset by net borrowings related to the Company's
commercial paper programs of $667.5, net cash proceeds from the January 2019
issuance of the 2029 Senior Notes of $499.5, and cash proceeds from the exercise
of stock options of $113.5.



The Company has significant flexibility to meet its financial commitments. The
Company uses debt financing to lower the overall cost of capital and increase
return on stockholders' equity. The Company's debt financing includes the use of
commercial paper programs, its Revolving Credit Facility and senior notes as
part of its overall cash management strategy.



On January 15, 2019, the Company amended its $2,000.0 unsecured credit facility
with a $2,500.0 unsecured credit facility ("Revolving Credit Facility"). The
Revolving Credit Facility, which matures January 2024, gives the Company the
ability to borrow, in various currencies, at a spread over LIBOR. The Company
may utilize the Revolving Credit Facility for general corporate purposes. At
June 30, 2020 and December 31, 2019, there were no outstanding borrowings under
the Revolving Credit Facility. The Revolving Credit Facility requires payment of
certain annual agency and commitment fees and requires that the Company satisfy
certain financial covenants. At June 30, 2020, the Company was in compliance
with the financial covenants under the Revolving Credit Facility.



Pursuant to the terms of the U.S. commercial paper program, the Company issues
short-term unsecured commercial paper notes ("USCP Notes") in one or more
private placements in the United States (the "U.S. Commercial Paper Program").
There were no USCP Notes outstanding as of June 30, 2020.



Pursuant to the terms of the euro-commercial paper program (the "Euro Commercial
Paper Program" and, together with the U.S. Commercial Paper Program, the
"Commercial Paper Programs"), the Company and one of its wholly owned European
subsidiaries (the "Euro Issuer") issues short-term unsecured commercial paper
notes (the "ECP Notes" and, together with the USCP Notes, the "Commercial
Paper"), which are guaranteed by the Company and are to be issued outside of the
United States.  The ECP Notes may be issued in Euros, Sterling, U.S. dollars or
other currencies. In addition, effective April 14, 2020, a subsidiary of the
Company is able to issue ECP Notes through the Bank of England's COVID Corporate
Financing Facility ("BOE Facility"). The BOE Facility will be available for at
least twelve months from its inception. The Company repaid all of its
outstanding ECP Notes in the second quarter of 2020, including under the BOE
Facility, and as such, there were no ECP Notes outstanding as of June 30, 2020.



Amounts available under the Commercial Paper Programs may be borrowed, repaid
and re-borrowed from time to time. In conjunction with the Revolving Credit
Facility, the authorization from the Company's Board of Directors limits the
maximum aggregate principal amount outstanding of USCP Notes, ECP Notes, and any
other commercial paper,

                                       32

  Table of Contents

euro-commercial paper or similar programs at any time to $2,500.0.  In addition,
the maximum aggregate principal amount outstanding of USCP Notes at any time is
$2,500.0. The maximum aggregate principal amount outstanding of ECP Notes at any
time is $2,000.0. The Commercial Paper Programs are rated A-2 by Standard &
Poor's and P-2 by Moody's and are currently backstopped by the Revolving Credit
Facility, as amounts undrawn under the Company's Revolving Credit Facility are
available to repay Commercial Paper, if necessary. Net proceeds of the issuances
of Commercial Paper are expected to be used for general corporate purposes. The
Company reviews its optimal mix of short-term and long-term debt regularly and
may replace certain amounts of Commercial Paper, short-term debt and current
maturities of long-term debt with new issuances of long-term debt in the future.



On March 20, 2020, the Company, through one of its wholly owned foreign
subsidiaries, borrowed $100.0 (the maximum borrowing capacity) on an uncommitted
line of credit, at a variable LIBOR-based interest rate, initially set at 1.92%.
This line of credit, which is guaranteed by the Company and carries an interest
rate of LIBOR plus 80 basis points, expires on December 19, 2020. Borrowings
under this line of credit arrangement were used for general corporate purposes.
Prior to maturity, on May 5, 2020, the Company repaid, in full, the outstanding
borrowing on this uncommitted line of credit, using cash and cash equivalents on
hand.



As of June 30, 2020, the Company has outstanding senior notes (the "Senior
Notes") as follows:




 Principal    Interest
  Amount        Rate              Maturity
$     227.7      3.125 %       September 2021
      295.0       4.00 %        February 2022
      350.0       3.20 %         April 2024
      400.0      2.050 %         March 2025
      500.0      4.350 %          June 2029
      900.0       2.80 %        February 2030

€     500.0      0.750 %    May 2026 (Euro Notes)

      500.0       2.00 %  October 2028 (Euro Notes)




On February 20, 2020, the Company issued $400.0 principal amount of unsecured
2.050% Senior Notes due March 1, 2025 at 99.829% of face value (the "2025 Senior
Notes"). On April 1, 2020, the Company used the net proceeds from the 2025
Senior Notes to repay the $400.0 2.20% Senior Notes due April 1, 2020 upon
maturity.



In January 2019, the Company issued $500.0 principal amount of unsecured 4.350%
Senior Notes due June 1, 2029 at 99.904% of face value (the "2029 Senior
Notes"), the net proceeds of which were used, along with proceeds from
borrowings under the U.S. Commercial Paper Program, to repay the $750.0 of the
Company's 2.55% Senior Notes due in January 2019.



All of the Company's outstanding senior notes in the United States ("U.S. Senior
Notes") are unsecured and rank equally in right of payment with the Company's
other unsecured senior indebtedness. Interest on each series of the U.S. Senior
Notes is payable semiannually. The Company may, at its option, redeem some or
all of any series of U.S. Senior Notes, subject to certain terms and conditions.



On May 4, 2020, the Euro Issuer issued €500.0 (approximately $545.4 at date of
issuance) principal amount of unsecured 0.750% Senior Notes due May 4, 2026 at
99.563% of face value (the "2026 Euro Notes" or "0.750% Euro Senior Notes" and
collectively with the 2028 Euro Notes, "Euro Notes"). The Company used the net
proceeds from the 2026 Euro Notes to repay amounts outstanding under its
Revolving Credit Facility.



The Euro Notes are unsecured and rank equally in right of payment with the Euro
Issuer's other unsecured senior indebtedness, and are fully and unconditionally
guaranteed on a senior unsecured basis by the Company. Interest on each series
of the Euro Notes is payable annually. The Company may, at its option, redeem
some or all of any series of Euro Notes, subject to certain terms and
conditions.



The Company's Senior Notes contain certain financial and non-financial covenants. Refer to Note 4 of the Condensed Consolidated Financial Statements for further information related to the Company's debt.



                                       33

  Table of Contents



In April 2018, the Company's Board of Directors authorized a stock repurchase
program under which the Company may purchase up to $2,000.0 of the Company's
Common Stock during the three-year period ending April 24, 2021 (the "2018 Stock
Repurchase Program") in accordance with the requirements of Rule 10b-18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company
did not repurchase any of its Common Stock during the three months ended June
30, 2020, while during the six months ended June 30, 2020, the Company
repurchased 2.7 million shares of its Common Stock for $257.2, all under the
2018 Stock Repurchase Program. All of the repurchased shares during the first
six months of 2020 have been retired by the Company. During the three months
ended June 30, 2019, the Company repurchased 2.6 million shares of its Common
Stock for $248.7, while during the six months ended June 30, 2019, the Company
repurchased 4.4 million shares of its Common Stock for $408.7, all under the
2018 Stock Repurchase Program. Of the total repurchases during the first six
months of 2019, 1.0 million shares, or $87.6, were retained in Treasury stock at
time of repurchase; the remaining 3.4 million shares, or $321.1, were retired by
the Company. The Company has not repurchased any additional shares of its Common
Stock from July 1, 2020 to July 21, 2020, and has remaining authorization to
purchase up to $587.9 of its Common Stock under the 2018 Stock Repurchase
Program. The price and timing of any future purchases under the 2018 Stock
Repurchase Program will depend on a number of factors such as levels of cash
generation from operations, the level of uncertainty relating to the COVID-19
pandemic, the volume of stock option exercises by employees, cash requirements
for acquisitions, dividends, economic and market conditions and stock price.



Contingent upon declaration by the Board of Directors, the Company generally
pays a quarterly dividend on shares of its Common Stock. The following table
summarizes the declared quarterly dividends per share as well as the dividends
declared and paid for the three and six months ended June 30, 2020 and 2019:




                                                    Three Months Ended
                                                         June 30,             Six Months Ended June 30,
                                                    2020          2019          2020             2019
Dividends declared per share                      $    0.25     $    0.23

$ 0.50 $ 0.46


Dividends declared                                $    74.6     $    68.3   $       148.6    $       136.8
Dividends paid (including those declared in
the prior year)                                        74.0          68.5           148.4            137.2




On July 23, 2019, the Company's Board of Directors approved an increase to its
quarterly dividend rate from $0.23 to $0.25 per share effective with dividends
declared in the third quarter of 2019.



Environmental Matters



Certain operations of the Company are subject to environmental laws and
regulations which govern the discharge of pollutants into the air and water, as
well as the handling and disposal of solid and hazardous wastes. The Company
believes that its operations are currently in substantial compliance with
applicable environmental laws and regulations and that the costs of continuing
compliance will not have a material adverse effect on the Company's financial
condition, results of operations or cash flows.



Non-GAAP Financial Measures



In addition to assessing the Company's financial condition, results of
operations, liquidity and cash flows in accordance with U.S. GAAP, management
utilizes certain non-GAAP financial measures defined below as part of its
internal reviews for purposes of monitoring, evaluating and forecasting the
Company's financial performance, communicating operating results to the
Company's Board of Directors and assessing related employee compensation
measures. Management believes that these non-GAAP financial measures may be
helpful to investors in assessing the Company's overall financial performance,
trends and period-over-period comparative results, in addition to the reasons
noted below. Non-GAAP financial measures related to operating income, operating
margin, net income attributable to Amphenol Corporation, effective tax rate and
diluted EPS exclude income and expenses that are not directly related to the
Company's operating performance during the periods presented. Items excluded in
such non-GAAP financial measures in any period may consist of, without
limitation, acquisition-related expenses, refinancing-related costs, and certain
discrete tax items including but not limited to (i) the excess tax benefits
related to stock-based compensation and (ii) the impact of significant changes
in tax law. Non-GAAP financial measures related to net sales exclude the impact

                                       34

  Table of Contents

related to foreign currency exchange and acquisitions. The non-GAAP financial
information contained herein is included for supplemental purposes only and
should not be considered in isolation, as a substitute for or superior to the
related U.S. GAAP financial measures. In addition, these non-GAAP financial
measures are not necessarily the same or comparable to similar measures
presented by other companies, as such measures may be calculated differently or
may exclude different items.



The non-GAAP financial measures defined below should be read in conjunction with
the Company's financial statements presented in accordance with U.S. GAAP. The
reconciliations of these non-GAAP financial measures to the most directly
comparable U.S. GAAP financial measures for the three and six months ended June
30, 2020 and 2019 are included in "Results of Operations" and "Liquidity and
Capital Resources" within this Item 2:



Adjusted Diluted EPS is defined as diluted earnings per share (as reported in

accordance with U.S. GAAP), excluding income and expenses and their specific

tax effects that are not directly related to the Company's operating

? performance during the periods presented. Adjusted Diluted EPS is calculated as

Adjusted Net Income attributable to Amphenol Corporation, as defined below,

divided by the weighted average outstanding diluted shares as reported in the


   Condensed Consolidated Statements of Income.




   Adjusted Effective Tax Rate is defined as Provision for income taxes, as

reported in the Condensed Consolidated Statements of Income, expressed as a

? percentage of Income before income taxes, as reported in the Condensed

Consolidated Statements of Income, each excluding the income and expenses and

their specific tax effects that are not directly related to the Company's


   operating performance during the periods presented.



Adjusted Net Income attributable to Amphenol Corporation is defined as Net

income attributable to Amphenol Corporation, as reported in the Condensed

? Consolidated Statements of Income, excluding income and expenses and their

specific tax effects that are not directly related to the Company's operating


   performance during the periods presented.



Adjusted Operating Income is defined as Operating income, as reported in the

? Condensed Consolidated Statements of Income, excluding income and expenses that

are not directly related to the Company's operating performance during the


   periods presented.



Adjusted Operating Margin is defined as Adjusted Operating Income (as defined

? above) expressed as a percentage of Net sales (as reported in the Condensed


   Consolidated Statements of Income).




   Constant Currency Net Sales Growth is defined as the period-over-period

percentage change in net sales growth, excluding the impact of changes in

foreign currency exchange rates. Amphenol's results are subject to volatility

? related to foreign currency translation fluctuations. As such, management

evaluates the Company's sales performance based on actual sales growth in U.S.

dollars, as well as Organic Net Sales Growth (defined below) and Constant

Currency Net Sales Growth, and believes that such information is useful to


   investors to assess the underlying sales trends.




   Free Cash Flow is defined as Net cash provided by operating activities

("Operating Cash Flow" - as reported in accordance with U.S. GAAP) less capital

expenditures (as reported in accordance with U.S. GAAP), both of which are

? derived from the Condensed Consolidated Statements of Cash Flow. Free Cash Flow

is an important liquidity measure for the Company, as we believe it is useful

for management and investors to assess our ability to generate cash, as well as

to assess how much cash can be used to reinvest in the growth of the Company or


   to return to shareholders through either stock repurchases or dividends.



Organic Net Sales Growth is defined as the period-over-period percentage change

in net sales growth resulting from operating volume and pricing changes, and

excludes the impact of 1) changes in foreign currency exchange rates, which

directly impact the Company's operating results and are outside the control of

the Company and 2) acquisitions closed since the beginning of the prior

? calendar year, which were not included in the Company's results as of the

comparable prior year periods and which do not reflect the underlying growth of

the Company on a comparative basis. Management evaluates the Company's sales

performance based on actual sales growth in U.S. dollars, as well as Constant

Currency Net Sales Growth (defined above) and Organic Net Sales Growth, and


   believes that such information is useful to investors to assess the underlying
   sales trends.




                                       35

  Table of Contents

Critical Accounting Policies and Estimates

The Company's disclosures of its critical accounting policies, which are contained in its 2019 Annual Report, have not materially changed since that report was filed.

© Edgar Online, source Glimpses